RxDoctor Payments DataLook up a doctor →

Thomas Chang

Foot & Ankle Surgery · Santa Rosa, CANPI 1841315736

Payments from drug & device makers

$2,110,400in general payments, 2019–2025

Across 465 payments — averaging $4538.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$1.2M
  • Depuy Synthes Products, Inc.$599K
  • Ossio Inc$91K
  • Ossio LTD$80K
  • Stryker$53K
  • Bioventus LLC$40K
  • plus $77K from 30 others
$9,258in research payments, 2019–2025

Across 9 payments — averaging $1028.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Paragon 28, Inc.$9K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,110,400 in reported general payments places this provider in the 95th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California

Medicare billing

Part B allowed, 2024
$421,639
Medicare patients
755
Services billed
4,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other foot & ankle surgery in Santa Rosa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →